FDA Expands Uses of Vyvanse to Treat Binge-Eating Disorder
The U.S. Food and Drug Administration today expanded the approved uses of Vyvanse (lisdexamfetamine dimesylate) to treat binge-eating disorder in adults. The drug is the first FDA-approved medication to treat this condition.
Put Down the Fork: Rx Could Curb Binge-Eating
Patients with binge-eating disorder face a lack of approved treatments for their condition. A new medication could give hope to these patients.